DeCODE Genetics purchased by Amgen
Icelandic company deCODE Genetics is to be purchased by Amgen, one of the world's largest biopharmaceutical companies, for $415 million it was announced this week.
Biotechnology giant Amgen is selling the Japanese rights to up to 13 of its experimental drugs to Takeda Pharmaceutical of Japan in a deal that might bring Amgen more than $1 billion.